Trial Profile
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 May 2014
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Female pattern baldness; Male pattern baldness
- Focus Pharmacokinetics
- Sponsors Allergan
- 22 May 2014 New trial record
- 12 Apr 2012
- 19 Jan 2011